Literature DB >> 17905147

Patient-important outcomes in diabetes--time for consensus.

Victor M Montori1, Gunjan Y Gandhi, Gordon H Guyatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17905147     DOI： 10.1016/S0140-6736(07)61489-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Rosiglitazone: a European regulatory perspective.

Authors:  E Blind; K Dunder; P A de Graeff; E Abadie
Journal:  Diabetologia       Date:  2010-12-14       Impact factor: 10.122

2.  Disparities in the hospital cost of cardiometabolic diseases among lesbian, gay, and bisexual Canadians: a population-based cohort study using linked data.

Authors:  Neeru Gupta; Zihao Sheng
Journal:  Can J Public Health       Date:  2020-02-28

Review 3.  Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.

Authors:  René Rodríguez-Gutiérrez; Victor M Montori
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-08-23

Review 4.  Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.

Authors:  Juan Pablo Domecq; Gabriela Prutsky; Aaron Leppin; M Bassam Sonbol; Osama Altayar; Chaitanya Undavalli; Zhen Wang; Tarig Elraiyah; Juan Pablo Brito; Karen F Mauck; Mohammed H Lababidi; Larry J Prokop; Noor Asi; Justin Wei; Salman Fidahussein; Victor M Montori; Mohammad Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2015-01-15       Impact factor: 5.958

Review 5.  Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kirstie L Haywood; Sophie Staniszewska; Sarah Chapman
Journal:  Qual Life Res       Date:  2011-05-18       Impact factor: 4.147

Review 6.  Effect of metformin on microvascular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  José Gerardo González-González; Ricardo Cesar Solis; Alejandro Díaz González-Colmenero; Karina Raygoza-Cortez; Pablo J Moreno-Peña; Alicia L Sánchez; Rozalina G McCoy; Naykky Singh Ospina; Spyridoula Maraka; Juan P Brito; René Rodriguez-Gutierrez
Journal:  Diabetes Res Clin Pract       Date:  2022-03-02       Impact factor: 8.180

7.  Increasing value and reducing waste in research design, conduct, and analysis.

Authors:  John P A Ioannidis; Sander Greenland; Mark A Hlatky; Muin J Khoury; Malcolm R Macleod; David Moher; Kenneth F Schulz; Robert Tibshirani
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

Review 8.  Minimizing hypoglycemia while maintaining glycemic control in diabetes.

Authors:  Simon R Heller
Journal:  Diabetes       Date:  2008-12       Impact factor: 9.461

Review 9.  Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.

Authors:  Bernd Richter; Elizabeth Bandeira-Echtler; Karla Bergerhoff; Christian Lerch
Journal:  Vasc Health Risk Manag       Date:  2008

Review 10.  Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic.

Authors:  David T Eton; Timothy J Beebe; Philip T Hagen; Michele Y Halyard; Victor M Montori; James M Naessens; Jeff A Sloan; Carrie A Thompson; Douglas L Wood
Journal:  Patient Relat Outcome Meas       Date:  2014-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.